Janssen

News

Janssen's Darzalex approved for myeloma in Europe

Darzalex, a first-in-class treatment for multiple myeloma has been approved in Europe, adding to an increasingly competitive disease area.

Articles

Janssen: tackling the big questions of balancing innovation,...

Paul Tunnah spoke to Jane Griffiths, company group chairman, Janssen pharma companies (Johnson & Johnson) EMEA, at the recent eyeforpharma Barcelona event about some of the big questions fa

Articles

Healthcare disrupted: four emerging business models

New technologies and new business models are transforming life science companies. A new book from Accenture maps out the fresh approaches being taken across healthcare.

Articles

Delivering pharma innovation: Takeda and Novo Nordisk on the...

Andrew McConaghie reviews the findings of the latest pharma ranking index, which assesses on the premise: if you gave the same molecule to two different companies in early phase, which would ma

News

AbbVie swoops for Pharmacyclics in $21bn takeover

Johnson & Johnson has missed out on acquiring its marketing partner Pharmacyclics after AbbVie snatched the company from under its nose with a $21 billion takeover.

Articles